Phibro Animal Health (PAHC) Q4 FY2026 earnings: revenue $397 million, up 4.8% on the year

Phibro Animal Health Corp. (PAHC) reported revenue of $397 million for Q4 FY2026, the quarter ended 30 June 2026, up 4.8% on the same quarter a year earlier. Net income was $22 million, up 26.0% on the year, and diluted earnings per share $0.52. The figures are the company's own, from the 10-K it filed with the SEC on 26 August 2026.

Revenue$397 millionup 4.8%

Net income$22 millionup 26.0%

Diluted EPS$0.52

QuarterQ4 FY2026ended 30 June 2026

What management said

Guidance figures: 7 new.

MFA acquisition drove full-year Animal Health growth to 21 percent: Animal Health net sales increased $199.4 million or 21% for full year to $1,162.2 million. MFAs and other increased $164.4 million or 25%, including $146.1 million from products acquired in MFA portfolio on October 31, 2024.
Fourth quarter gross margin expanded 490 basis points: Fourth quarter gross profit margin increased to 33.9% from 29.0%, a 490 basis point improvement. Excluding acquisition-related items, margin increased 380 bps to 34.6% due to higher sales volume, favorable product mix, and increases in average selling prices.
Full year gross margin up 290 basis points to 33.8 percent: Annual gross profit increased $112.6 million or 28% to $512.5 million. Gross margin expanded from 30.9% to 33.8%, or 290 basis points. Adjusted for non-recurring items, margin expanded 230 bps to 34.6% due to increased sales and favorable product mix.

Read the earnings call summary

The quarter, against the one before and a year earlier

Line	Q4 FY2026	Q3 FY2026	Q4 FY2025	Change on the year
Revenue	397	384	379	+4.8%
Cost of revenue	262	258	269	-2.4%
Gross profit	134	126	110	+22.2%
Gross margin	33.9%	32.8%	29.0%
Selling, general and administrative	86.2	81.0	76.3	+13.0%
Operating income	48.2	44.7	33.7	+42.8%
Operating margin	12.1%	11.6%	8.9%
Interest expense	10.7	10.7	9.0	+18.6%
Pre-tax income	32.3	32.3	23.8	+35.6%
Income tax	10.6	8.3	6.6	+60.5%
Effective tax rate	32.9%	25.7%	27.8%
Net income	21.7	24.0	17.2	+26.0%
Net margin	5.5%	6.3%	4.5%
Diluted EPS	$0.52	$0.59	$0.43	+20.9%

$ million except per share.

Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q4 FY2026	Q3 FY2026	Q4 FY2025	Change on the year
Operating cash flow	24.1	16.2	21.3	+13.3%
Capital expenditure	18.9	15.3	13.1	+43.6%
Free cash flow	5.2	0.9	8.1	-35.7%
Free cash flow margin	1.3%	0.2%	2.1%
Cash from investing	-16.5	-16.8	-7.0	n/a
Cash from financing	-1.6	-2.3	-7.8	n/a
Depreciation and amortisation	13.3	12.4	12.4	+7.5%
Share-based compensation	0.4	0.4	0.2	+130.7%
Dividends paid	4.9	4.9	4.9	+0.1%
Dividend per share	n/a	$0.12	n/a	n/a
Diluted shares, weighted	41m	41m	41m	+0.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q4 FY2026	Q3 FY2026	Q4 FY2025	Change on the year
Shareholders' equity	385	362	286	+34.9%
Debt	738	621	632	+16.8%
Operating lease liabilities	45.4	42.5	33.7	+34.6%
Other liabilities	332	420	410	-18.9%
Total liabilities and equity	1,501	1,445	1,361	+10.3%
Fixed assets	369	359	355	+4.1%
Goodwill	60.0	59.9	59.6	+0.7%
Intangible assets	30.1	31.7	36.5	-17.6%
Investments	20.6	22.5	9.0	+128.6%
Cash and equivalents	61.4	54.9	68.0	-9.7%
Receivables	239	222	228	+4.7%
Inventory	535	540	444	+20.4%
Other assets	186	156	161	+16.0%
Total assets	1,501	1,445	1,361	+10.3%

Questions

What was Phibro Animal Health's revenue in Q4 FY2026?

Phibro Animal Health (PAHC) reported revenue of $397 million for Q4 FY2026, the quarter ended 30 June 2026, up 4.8% on the same quarter a year earlier.

How much did Phibro Animal Health earn in Q4 FY2026?

Net income for Q4 FY2026 was $22 million, up 26.0% on the year, and diluted earnings per share $0.52.

When did Phibro Animal Health report Q4 FY2026 results?

Phibro Animal Health filed its 10-K for the year that ended with the quarter on 26 August 2026; the fourth quarter is the year less the first three.

Quarterly results, the last 12 quarters

	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026	Q4 FY2026 *
Revenue	231	250	263	273	260	309	348	379	364	374	384	397
Cost of revenue	164	171	184	186	177	207	243	269	244	241	258	262
Gross profit	67.7	78.6	79.6	87.2	83.5	102	105	110	120	133	126	134
Gross margin	29%	31%	30%	32%	32%	33%	30%	29%	33%	35%	33%	34%
SG&A	68.5	62.9	59.7	68.7	65.8	76.3	71.1	76.3	68.5	82.3	81.0	86.2
Operating income	-0.7	15.7	19.9	18.4	17.7	25.5	33.5	33.7	51.3	50.3	44.7	48.2
Operating margin	-0%	6%	8%	7%	7%	8%	10%	9%	14%	13%	12%	12%
Interest expense	5.6	5.7	5.6	6.0	8.8	9.8	9.7	9.0	12.5	12.5	10.7	10.7
Pre-tax income	-12.0	3.6	12.9	6.4	9.6	4.8	29.7	23.8	36.3	36.4	32.3	32.3
Tax rate	n/a	64%	35%	88%	27%	34%	30%	28%	27%	25%	26%	33%
Net income	-8.0	1.3	8.4	0.8	7.0	3.2	20.9	17.2	26.5	27.5	24.0	21.7
Net margin	-3%	1%	3%	0%	3%	1%	6%	5%	7%	7%	6%	5%
Diluted EPS	-$0.20	$0.03	$0.21	$0.02	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.52
Operating cash flow	16.2	31.6	11.4	28.4	12.6	3.1	43.2	21.3	9.3	19.4	16.2	24.1
Capital expenditure	7.5	11.0	9.7	13.1	9.6	7.8	7.7	13.1	13.8	11.1	15.3	18.9
Free cash flow	8.7	20.6	1.7	15.4	3.0	-4.7	35.4	8.1	-4.5	8.3	0.9	5.2
Dividends paid	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9
Filing	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 30 June 2026, filed 26 August 2026, accession 0001104659-26-101493: the filing on EDGAR. All of Phibro Animal Health Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install